Table 4.
Potential adverse effects after treatment in patients enrolled in the study comparing treatment 7 groups.
| Artequick(1) | Artequick(2) | ASMQ | Artequick(3) | Artequick(4) | Artekin | Coartem | |
|---|---|---|---|---|---|---|---|
| Headache | 5 (31) | 12 (35) | 3 (12) | 20 (32) | 14 (25) | 8 (10) | 5 (6) |
| Weakness | 4 (25) | 7 (20) | 2 (8) | 17 (27) | 5 (9) | 9 (11) | 7 (9) |
| Dizziness | 4 (25) | 7 (20) | 3 (12) | 19 (30) | 4 (7) | 7 (8) | 5 (6) |
| Anorexia | 1 (6) | 5 (15) | 1 (4) | 5 (8) | 2 (3) | 4 (5) | 4 (5) |
| Nausea | 1 (6) | 5 (15) | 3 (12) | 8 (13) | 2 (3) | 4 (5) | 3 (4) |
| Vomiting | 0 | 2 (6) | 2 (8) | 1 (1) | 0 | 4 (5) | 0 |
| Insomnia | 2 (12) | 4 (12) | 1 (4) | 7 (12) | 4 (7) | 9 (11) | 3 (4) |
| Abdominal pain | 4 (25) | 4 (12) | 1 (4) | 9 (14) | 5 (9) | 8 (10) | 5 (6) |
| Diarrhea | 2 (12) | 1 (3) | 0 | 4 (6) | 2 (3) | 3 (4) | 1 (1) |
Data are number (%) of patients.